To evaluate the ability of pediatric patients with suspected IBD to ingest a new oral contrast agent at CT or MR enterography (CTE/MRE) and to determine the impact on small bowel (SB) distension and diagnostic confidence.
To evaluate the ability of pediatric patients with suspected IBD to ingest a new oral contrast agent at CT or MR enterography (CTE/MRE) and to determine the impact on small bowel (SB) distension and diagnostic confidence.